发明名称 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
摘要 The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly modified to provide an artificial tear formulation.
申请公布号 US2014378401(A1) 申请公布日期 2014.12.25
申请号 US201314132822 申请日期 2013.12.18
申请人 GNT, LLC 发明人 Horn Gerald
分类号 A61K47/38;A61K31/4174;A61K47/02;A61K47/18;A61K31/138;A61K31/542;A61K31/546;A61K38/13;A61K31/498;A61K31/55;A61K31/724;A61K31/7052;A61K31/47;A61K31/4439;A61K31/4709;A61K31/53;A61K31/444;A61K47/34 主分类号 A61K47/38
代理机构 代理人
主权项 1. An ophthalmic drug delivery composition comprising from about 1% to about 15% w/v nonionic surfactant, one or more non-Newtonian high blend viscosity enhancing, non-gelling agents and from about 0.025% to about 0.90% sodium chloride, such that: i. final composition viscosity at shear rates representative of a non-blinking eye is between 50 and 100 cps; ii. final composition viscosity at shear rates representative of a blinking eye of less than 30 cps but remaining above 5 cps, even after 30% dilution; and iii. a final composition ratio of i./ii. of 3:1 or greater,wherein w/v denotes weight by volume.
地址 Dana Point CA US